The Hain Celestial Group, Inc. (NASDAQ:HAIN – Get Free Report) has earned a consensus recommendation of “Hold” from the eleven analysts that are presently covering the firm, MarketBeat reports. Ten research analysts have rated the stock with a hold rating and one has assigned a buy rating to the company. The average twelve-month price target among brokers that have issued ratings on the stock in the last year is $3.5889.
Several equities analysts recently weighed in on the stock. Zacks Research raised shares of The Hain Celestial Group from a “strong sell” rating to a “hold” rating in a research note on Tuesday, August 19th. Mizuho cut their target price on shares of The Hain Celestial Group from $3.00 to $2.50 and set a “neutral” rating for the company in a research note on Monday, July 28th. Finally, Piper Sandler cut their target price on shares of The Hain Celestial Group from $2.00 to $1.80 and set a “neutral” rating for the company in a research note on Tuesday, June 3rd.
Check Out Our Latest Report on HAIN
Hedge Funds Weigh In On The Hain Celestial Group
The Hain Celestial Group Stock Performance
HAIN opened at $1.91 on Friday. The stock has a market capitalization of $172.38 million, a price-to-earnings ratio of -0.66 and a beta of 0.79. The company has a fifty day moving average of $1.72 and a 200 day moving average of $2.42. The Hain Celestial Group has a fifty-two week low of $1.30 and a fifty-two week high of $9.43. The company has a debt-to-equity ratio of 1.01, a quick ratio of 0.99 and a current ratio of 1.81.
The Hain Celestial Group Company Profile
The Hain Celestial Group, Inc manufactures, markets, and sells organic and natural products in United States, United Kingdom, Europe, and internationally. It operates through two segments: North America and International. The company offers infant formula; infant, toddler, and kids' food; plant-based beverages and frozen desserts, such as soy, rice, oat, and spelt; and condiments.
Read More
- Five stocks we like better than The Hain Celestial Group
- 3 Healthcare Dividend Stocks to Buy
- Is Qualcomm Tesla’s Next Rival in Autonomous Driving?
- Financial Services Stocks Investing
- 3 Under-the-Radar Biotechs Under $5 That Could Soar 200%
- What is the MACD Indicator and How to Use it in Your Trading
- The Quiet Before the Catalyst: Vertical Aerospace’s Next Move
Receive News & Ratings for The Hain Celestial Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for The Hain Celestial Group and related companies with MarketBeat.com's FREE daily email newsletter.